SCHEMBL7020106

SCHEMBL7020106

Nc1ncnc2c1c(-c1ccc(O)cc1)cn2C1CCNCC1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 17/20 0.87
EGFR P00533 9/20 0.87
ABL1 P00519 8/20 0.87
ABL2 P42684 8/20 0.87
RIPK2 O43353 2/20 0.77
FGR P09769 1/20 0.77
EPHA1 P21709 1/20 0.77
TXK P42681 1/20 0.77
FRK P42685 1/20 0.77
PTK6 Q13882 1/20 0.77
LCK P06239 3/20 0.72
TEK Q02763 1/20 0.72
JAK2 O60674 1/20 0.61
NTRK1 P04629 1/20 0.61
INSR P06213 1/20 0.61
NPM1 P06748 1/20 0.61
CSF1R P07333 1/20 0.61
LYN P07948 1/20 0.61
RET P07949 1/20 0.61
IGF1R P08069 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7019904 0.93 SRC (1.00) SRCEGFRABL1ABL2RIPK2
Hydrochloric Acid SCHEMBL8107815 0.92 SRC (0.98) SRCEGFRABL1ABL2RIPK2
SCHEMBL13020337 0.88 SRC (0.72) SRCEGFRABL1ABL2RIPK2
Hydrochloric Acid SCHEMBL7098308 0.87 SRC (0.85) SRCEGFRABL1ABL2RIPK2
SCHEMBL7018367 0.87 FGR (1.00) SRCEGFRABL1ABL2FGR
SCHEMBL6867601 0.86 SRC (0.80) SRCEGFRABL1ABL2RIPK2
SCHEMBL8098939 0.85 SRC (0.88) SRCEGFRABL1ABL2RIPK2
SCHEMBL6465227 0.84 SRC (1.00) SRCEGFRABL1PTK6LCK
SCHEMBL27397203 0.83 SRC (0.67) SRCEGFRABL1ABL2RIPK2
Hydrochloric Acid SCHEMBL6465660 0.83 SRC (0.98) SRCEGFRABL1PTK6LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888353-B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2003-07-09 EP disclosed
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed